Search
× Search

Baza informacij za delovanje Partnerjev Mreže Modro Poslovanje

0 0

CELEX:62022CJ0286_RES: Judgment of the Court (Fifth Chamber) of 12 October 2023.#KBC Verzekeringen NV v P&V Verzekeringen CVBA.#Request for a preliminary ruling from the Hof van Cassatie.#Reference for a preliminary ruling – Insurance against civil liability in respect of the use of motor vehicles – Directive 2009/103/EC – Point 1 of Article 1 – Concept of a ‘vehicle’ – National legislation providing for the automatic compensation of certain road users who are the victims of a road accident – Person not driving a ‘motor vehicle’ within the meaning of that legislation – Concept equivalent to that of ‘vehicle’ within the meaning of Directive 2009/103 – Bicycle equipped with an electric motor providing pedal assistance, equipped with a boost function which can be activated only after the use

0 0

CELEX:62022CJ0288: Judgment of the Court (Third Chamber) of 21 December 2023.#TP v Administration de l'enregistrement, des domaines et de la TVA.#Reference for a preliminary ruling – Taxation – Common system of value added tax (VAT) – Directive 2006/112/EC – Article 9 – Taxable persons – Economic activity carried out independently – Concept of ‘economic activity’ – Concept of ‘independent exercise of the activity’ – Activity as a member of the board of directors of a public limited company.#Case C-288/22.

0 0

CELEX:62022CJ0291: Judgment of the Court (Fourth Chamber) of 14 March 2024.#Debregeas et associés Pharma (D & A Pharma) v European Commission and European Medicines Agency.#Appeal – Medicinal products for human use – Application for marketing authorisation – Independence of experts consulted by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) – Article 41 of the Charter of Fundamental Rights of the European Union – Right to good administration – Requirement of objective impartiality – Criteria for verifying the absence of conflict of interest – EMA’s policy on competing interests – Activities as a principal researcher, consultant or strategic adviser for the pharmaceutical industry – Rival products – Re-examination procedure – Regulation (EC)

0 0

CELEX:62022CJ0291_RES: Judgment of the Court (Fourth Chamber) of 14 March 2024.#Debregeas et associés Pharma (D & A Pharma) v European Commission and European Medicines Agency.#Appeal – Medicinal products for human use – Application for marketing authorisation – Independence of experts consulted by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) – Article 41 of the Charter of Fundamental Rights of the European Union – Right to good administration – Requirement of objective impartiality – Criteria for verifying the absence of conflict of interest – EMA’s policy on competing interests – Activities as a principal researcher, consultant or strategic adviser for the pharmaceutical industry – Rival products – Re-examination procedure – Regulation

0 0

CELEX:62022CJ0292_SUM: Judgment of the Court (Tenth Chamber) of 15 June 2023.#Teritorialna direktsia Mitnitsa Varna v 'NOVA TARGOVSKA KOMPANIA 2004' AD.#Request for a preliminary ruling from the Administrativen sad - Varna.#Reference for a preliminary ruling – Customs union – Common Customs Tariff – Classification of goods – Combined Nomenclature – Headings 1511 and 1517 – Refined palm oil, bleached and deodorised – No method laid down for analysing the consistency of a product.#Case C-292/22.

0 0

CELEX:62022CJ0293: Judgment of the Court (Fourth Chamber) of 9 November 2023.#Chemours Netherlands BV v European Chemicals Agency.#Appeal – Regulation (EC) No 1907/2006 (REACH Regulation) – Article 57(f) – Substances of very high concern – Identification – Conditions – Serious effects on health or the environment – Equivalent level of concern – 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid, its salts and its acyl halides – Identification as a substance fulfilling the criteria for inclusion in Annex XIV to that regulation.#Case C-293/22 P.

0 0

CELEX:62022CJ0293_INF: Judgment of the Court (Fourth Chamber) of 9 November 2023.#Chemours Netherlands BV v European Chemicals Agency.#Appeal – Regulation (EC) No 1907/2006 (REACH Regulation) – Article 57(f) – Substances of very high concern – Identification – Conditions – Serious effects on health or the environment – Equivalent level of concern – 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid, its salts and its acyl halides – Identification as a substance fulfilling the criteria for inclusion in Annex XIV to that regulation.#Case C-293/22 P.

0 0

CELEX:62022CJ0294: Judgment of the Court (Fourth Chamber) of 5 October 2023.#Office français de protection des réfugiés et apatrides, OFPRA v SW.#Reference for a preliminary ruling – Common policy on asylum and subsidiary protection – Directive 2011/95/EU – Article 12 – Exclusion from being a refugee – Person registered with the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) – Conditions for that person to be entitled ipso facto to the benefits of Directive 2011/95 – Cessation of UNRWA protection or assistance – Failure to provide medical care – Conditions.#Case C-294/22.

RSS
First15481549155015511553155515561557Last

Poišči članke o davkih v bazi Modro poslovanje

Terms Of UsePrivacy StatementCopyright 2014-2014 by Srobotnik d.o.o.
Back To Top